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As a step toward understanding of the tissue specificity of cellular transformation by RNA tumor viruses 
we looked for the presence of a putative brain specific regulatory (identifier) sequence (C82B) in the genome 
of various oncornaviruses. The genomes of Harvey murine sarcoma virus and Rous sarcoma virus contain 
sequences flanking the viral oncogenes with > 80% and > 60% homology to C82B, respectively. We suggest 
that identifier sequences acquired by oncoviruses may determine the potential target cells of malignant 
transformation after virus penetration. 
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1. INTRODUCTION 
Harvey murine sarcoma virus (Ha-MuSV), a 
replication defective retrovirus, was isolated during 
the course of routine passage of Moloney murine 
leukemia virus (MO-MuLV) in rats [1,2]. Besides 
MO-MuLV related sequences the genome of Ha- 
MuSV contains a rat-derived sequence responsible 
for transformation of fibroblasts [3]. This region 
encodes a 21-kDa phosphoprotein (p2lhas), the 
putative ‘transforming protein’ of Ha-MuSV [4]. 
The nucleotide sequence of the gene coding for 
p2lhas (v-has) has been determined [5], and two 
control regions of a potential RNA polymerase III 
promoter have been localized upstream from the 
potential translational initiation codons of v-has. 
However, the physiological significance of these 
sequences in determining transcripts within the 
Ha-MuSV genome in vivo has not yet been assessed. 
Here we demonstrate that the same region shows a 
greater than 80% homology to a brain specific 
identifier (ID) sequence (C82B) potentially involved 
in the regulation of tissue-specific gene expression 
[6]. We also show that the intercistronic region 
(6863-7037 nucleotides) of Rous sarcoma virus 
(RSV) - a retrovirus capable of inducing neuro- 
genie tumors in many species including rats - 
contains a sequence with a less stringent homology 
to C82B as well. 
We hypothesize that the homology between 
identifier sequences and flanking sequences of 
viral one genes may play a role in determining the 
tissue specificity of transformation by retroviruses. 
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Fig.1. Sequence homologies (boxed areas) between a common 8Znucleotide sequence unique to brain RNA (C82B, 
nucleotides 1116-1197 of clone plB224 in 161) and the S’-flanking region of the v-has gene of Ha-MuSV 151. The 
sequences were. aligned for maximum homology. The figures above and below letters refer to the positions of nucleotide 
residues. Percent homology was calculated as follows: 
070 homology = 
No. of identical residues 
x loo 
No. of aligned residues + No. of gaps 
The putative RNA polymerase control regions in the Ha-MuSV genome are between positions 52-63 and 112-123. 
2. RESULTS AND DISCUSSION 
As a step toward understanding the tissue speci- 
ficity of transformation by RNA tumor viruses we 
looked for the presence of sequences homologous 
to a putative brain specific regulatory sequence [6] 
in the genome of various oncornaviruses. A com- 
puter-aided inspection of the primary structures of 
C82B and the 5’-half of the Ha-MuSV genome 
revealed that 80% of the sequence of C82B is 
homologous to a region localized upstream from 
the v-has gene (fig.1). 
To look for the possible origin of the ID-like 
sequence in the Ha-MuSV genome, we compared 
C82B and its inverse complement with the nucleo- 
tide sequence of the cellular has gene (c-has). Un- 
fortunately, the rat c-has primary structure is not 
available. The published human c-has sequences 
[7,8] - including their introns and flanking 5’ and 
3’-regions - do not contain the ID-like sequence, 
in spite of the presence of short homologous 
nucleotide stretches. C82B is also absent from the 
flanking regions of YP2 gene, coding for a protein 
homologous to p21 has in yeast [9]. We suggest hat 
the Ha-MuSV genome arose by multiple recombi- 
nation events between the MO-MuLV genome, an 
ID-like sequence and other rat-derived sequences. 
The intercistronic region of Rous sarcoma virus 
(Prague C strain) (nucleotides 6863-7037) is a 
17%nucleotide region between the env and v-src 
genes [lo]. Comparison of this sequence with 
C82B is shown in fig.2. The degree of homology is 
>60% between positions 4-63 of C82B and nucleo- 
tides 6948-6994 ?f the intercistronic region. Fur- 
thermore, an oligo (A) stretch (position 7018-7023) 
is localized following a region of non-homology 
downstream from the homologous sequences. 
The C82B-homologous region of the RSV ge- 
nome is part of a direct repeat flanking the v-src 
gene. Nucleotides 6897-6989 of the intercis- 
tronic region are directly repeated - with 82% 
homology - on the 3’-side of the v-src gene 
(nucleotides 8791-8890) [IO]. 
The homology of nucleotides 8852-8890 of the 
3’ direct repeat with C82B is 47.5%. This is com- 
parable with the degree of homology found be- 
tween small nuclear RNAs Ul and U4 [ 1 l]. 
Sutcliffe et al. [12] proposed that tr~scription 
of ID sequences located in the introns of brain 
genes by RNA polymerase III activates these genes 
for RNA polymerase II transcription. The presence 
of a putative RNA polymerase III promotor and 
an ID-like sequence in the vicinity of v-has suggests 
that a similar mechanism may participate in the 
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C82B ccccAGcTccGAAAAAAA 
Rev AGATAZWTCTTGCATAGGGGGAAAAAA 
69 ‘1023 
Fig.2. Sequence homologies (boxed areas) between a common 82-nucleotide sequence unique to brain RNA (C82B, 
nucleotides 1116-l 197 of clone plB224 in [6]) and sequences of the intercistronic region (nucleotides 6863-7037) of 
the Rous sarcoma virus [lo]. The figures above and below letters refer to the positions of nucleotide residues. 
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regulation of the expression of this viral oncogene. 
Furthermore, we suggest that Ha-MuSV is capable 
of transforming neuroblasts and/or neurogenic 
tissues. The intercistronic region of RSV - a retro- 
virus with well documented capabilities of inducing 
neurogenic tumors and transforming retinoblasts 
[13,14] - also shows a less stringent but significant 
homology to C82B. This region might contribute 
to the tissue specificity of cell transformation by 
RSV. We suggest hat ID sequences and/or tissue- 
specific enhancers acquired by oncoviruses may 
determine the potential target cells of malignant 
transformation after virus penetration. 
Note: After completion of this manuscript we 
learned that the homology between C82B and Ha- 
MuSV was also noticed but not discussed from the 
point of view of tissue-specific transformation by 
Milner et al. [15]. 
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